Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During Infancy

[1]  Sara M. Johnson,et al.  Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection , 2017, The Journal of infectious diseases.

[2]  L. Kauvar,et al.  Respiratory Syncytial Virus: Targeting the G Protein Provides a New Approach for an Old Problem , 2017, Journal of Virology.

[3]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[4]  H. Zar,et al.  Respiratory syncytial virus hospitalization and mortality: Systematic review and meta‐analysis , 2016, Pediatric pulmonology.

[5]  A. Marchant,et al.  Towards Predicting Protective Vaccine Responses in the Very Young. , 2016, Trends in immunology.

[6]  L. Jouneau,et al.  Flt3 ligand improves the innate response to respiratory syncytial virus and limits lung disease upon RSV reexposure in neonate mice , 2016, European journal of immunology.

[7]  M. D. de Jonge,et al.  Mucosal IgG Levels Correlate Better with Respiratory Syncytial Virus Load and Inflammation than Plasma IgG Levels , 2015, Clinical and Vaccine Immunology.

[8]  E. Walsh,et al.  Effect of Preexisting Serum and Mucosal Antibody on Experimental Respiratory Syncytial Virus (RSV) Challenge and Infection of Adults. , 2015, The Journal of infectious diseases.

[9]  S. Cormier,et al.  Crawling with Virus: Translational Insights from a Neonatal Mouse Model on the Pathogenesis of Respiratory Syncytial Virus in Infants , 2015, Journal of Virology.

[10]  Loreto Egaña,et al.  Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice , 2015, Respiratory Research.

[11]  S. Cormier,et al.  Building a better neonatal mouse model to understand infant respiratory syncytial virus disease , 2015, Respiratory Research.

[12]  J. Wrammert,et al.  Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus. , 2015, American journal of respiratory and critical care medicine.

[13]  F. Polack,et al.  TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization. , 2015, The Journal of clinical investigation.

[14]  E. Walsh,et al.  Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh. , 2014, The Journal of infectious diseases.

[15]  Young-In Kim,et al.  Limited Type I Interferons and Plasmacytoid Dendritic Cells during Neonatal Respiratory Syncytial Virus Infection Permit Immunopathogenesis upon Reinfection , 2014, Journal of Virology.

[16]  S. Turvey,et al.  Attenuation of Respiratory Syncytial Virus–Induced and RIG-I–Dependent Type I IFN Responses in Human Neonates and Very Young Children , 2014, The Journal of Immunology.

[17]  J. Tregoning,et al.  Delayed Sequelae of Neonatal Respiratory Syncytial Virus Infection Are Dependent on Cells of the Innate Immune System , 2013, Journal of Virology.

[18]  Avi Ma'ayan,et al.  Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.

[19]  C. Vinuesa,et al.  Innate B cell helpers reveal novel types of antibody responses , 2013, Nature Immunology.

[20]  J. Slupsky,et al.  Respiratory syncytial virus infection of airway epithelial cells, in vivo and in vitro, supports pulmonary antibody responses by inducing expression of the B cell differentiation factor BAFF , 2012, Thorax.

[21]  J. Mcghee,et al.  Inside the Mucosal Immune System , 2012, PLoS biology.

[22]  J. Mcghee,et al.  Novel vaccine development strategies for inducing mucosal immunity , 2012, Expert review of vaccines.

[23]  S. Cormier,et al.  The use of a neonatal mouse model to study respiratory syncytial virus infections , 2010, Expert review of anti-infective therapy.

[24]  B. Finlay,et al.  The future of mucosal immunology: studying an integrated system-wide organ , 2010, Nature Immunology.

[25]  S. Madhi,et al.  Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis , 2010, The Lancet.

[26]  K. Poehling,et al.  The burden of respiratory syncytial virus infection in young children. , 2009, The New England journal of medicine.

[27]  W. Khan.  B Cell Receptor and BAFF Receptor Signaling Regulation of B Cell Homeostasis1 , 2009, The Journal of Immunology.

[28]  H. Kiyono,et al.  Mucosal immunosenescence: new developments and vaccines to control infectious diseases. , 2009, Trends in immunology.

[29]  A. Coyle,et al.  Innate immune signals modulate antiviral and polyreactive antibody responses during severe respiratory syncytial virus infection. , 2009, The Journal of infectious diseases.

[30]  R. Lindsay,et al.  Infection of mice with respiratory syncytial virus during neonatal life primes for enhanced antibody and T cell responses on secondary challenge , 2008, Clinical and experimental immunology.

[31]  M. Akkoyunlu,et al.  Deficient TACI Expression on B Lymphocytes of Newborn Mice Leads to Defective Ig Secretion in Response to BAFF or APRIL1 , 2008, The Journal of Immunology.

[32]  R. Tisch,et al.  Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice , 2007, Proceedings of the National Academy of Sciences.

[33]  B. Graham,et al.  Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis , 2007, Journal of Virology.

[34]  M. Busslinger,et al.  Pax5: the guardian of B cell identity and function , 2007, Nature Immunology.

[35]  N. Lukacs,et al.  Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus , 2006, The Journal of experimental medicine.

[36]  O. Ramilo,et al.  Comparative Effects of Two Neutralizing Anti-Respiratory Syncytial Virus (RSV) Monoclonal Antibodies in the RSV Murine Model: Time versus Potency , 2005, Antimicrobial Agents and Chemotherapy.

[37]  B. He,et al.  Plasmacytoid dendritic cells and the regulation of immunoglobulin heavy chain class switching , 2005, Immunology and cell biology.

[38]  Sambasiva P Rao,et al.  B Cell-Activating Factor Belonging to the TNF Family Acts through Separate Receptors to Support B Cell Survival and T Cell-Independent Antibody Formation , 2004, The Journal of Immunology.

[39]  E. Walsh,et al.  Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults. , 2004, The Journal of infectious diseases.

[40]  C. Leclerc,et al.  Neonatal adaptive immunity comes of age , 2004, Nature Reviews Immunology.

[41]  R. Rabin,et al.  Suppression of the Induction of Alpha, Beta, and Lambda Interferons by the NS1 and NS2 Proteins of Human Respiratory Syncytial Virus in Human Epithelial Cells and Macrophages , 2004, Journal of Virology.

[42]  O. Ramilo,et al.  Anti-Respiratory Syncytial Virus (RSV) Neutralizing Antibody Decreases Lung Inflammation, Airway Obstruction, and Airway Hyperresponsiveness in a Murine RSV Model , 2004, Antimicrobial Agents and Chemotherapy.

[43]  Peter L. Collins,et al.  Suppression of the Induction of Alpha, Beta, and Gamma Interferons by the NS1 and NS2 Proteins of Human Respiratory Syncytial Virus in Human Epithelial Cells and Macrophages , 2004, Journal of Virology.

[44]  R. Bram,et al.  BCMA Is Essential for the Survival of Long-lived Bone Marrow Plasma Cells , 2004, The Journal of experimental medicine.

[45]  K. Conzelmann,et al.  Nonstructural Proteins NS1 and NS2 of Bovine Respiratory Syncytial Virus Block Activation of Interferon Regulatory Factor 3 , 2003, Journal of Virology.

[46]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[47]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[48]  J. V. van Deursen,et al.  Regulation of the T-independent humoral response by TACI. , 2001, Immunity.

[49]  B. Mellen,et al.  Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. , 2000, The Journal of pediatrics.

[50]  T. Iwasaki,et al.  Isolation and characterization of mouse nasal-associated lymphoid tissue. , 1997, Journal of immunological methods.

[51]  J. Forster,et al.  The humoral immune response of children and infants to an RSV infection: its maturation and association with illness , 1995, Klinische Padiatrie.

[52]  E. Wang,et al.  Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. , 1995, The Journal of pediatrics.

[53]  M. Marinaro,et al.  Mucosal immunity to infection with implications for vaccine development. , 1994, Current opinion in immunology.

[54]  N. Roberts,et al.  The limited role of the human interferon system response to respiratory syncytial virus challenge: analysis and comparison to influenza virus challenge. , 1992, Microbial pathogenesis.

[55]  A. Hislop,et al.  Airway size and structure in the normal fetal and infant lung and the effect of premature delivery and artificial ventilation. , 1989, The American review of respiratory disease.

[56]  K. Mcintosh.  Interferon in nasal secretions from infants with viral respiratory tract infections. , 1978, The Journal of pediatrics.

[57]  R. Douglas,et al.  Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections. , 1978, The Journal of pediatrics.

[58]  L. Anderson,et al.  Clinical and epidemiologic features of respiratory syncytial virus. , 2013, Current topics in microbiology and immunology.

[59]  J. Stockman,et al.  The Burden of Respiratory Syncytial Virus Infection in Young Children , 2010 .

[60]  E. Torbicka,et al.  The immune response of small children by antibodies of different classes to respiratory syncytial virus (RSV) proteins. , 1994, Acta microbiologica Polonica.